Natural medicine delivery from 3D printed bone substitutes

被引:17
作者
Bose, Susmita [1 ]
Sarkar, Naboneeta [1 ]
Jo, Yongdeok [1 ]
机构
[1] Washington State Univ, Sch Mech & Mat Engn, W M Keck Biomed Mat Res Lab, Pullman, WA 99164 USA
基金
美国国家卫生研究院;
关键词
3D printing; Bone implant; Drug delivery; Natural products; Herbal medicine; TRICALCIUM PHOSPHATE SCAFFOLDS; ENDOPLASMIC-RETICULUM STRESS; CALCIUM-PHOSPHATE; DRUG-DELIVERY; IN-VITRO; CONTROLLED-RELEASE; GROWTH-FACTOR; SURFACE MODIFICATION; OSTEOGENIC DIFFERENTIATION; ANTIMICROBIAL PEPTIDES;
D O I
10.1016/j.jconrel.2023.09.025
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Unmet medical needs in treating critical-size bone defects have led to the development of numerous innovative bone tissue engineering implants. Although additive manufacturing allows flexible patient-specific treatments by modifying topological properties with various materials, the development of ideal bone implants that aid new tissue regeneration and reduce post-implantation bone disorders has been limited. Natural biomolecules are gaining the attention of the health industry due to their excellent safety profiles, providing equivalent or superior performances when compared to more expensive growth factors and synthetic drugs. Supplementing additive manufacturing with natural biomolecules enables the design of novel multifunctional bone implants that provide controlled biochemical delivery for bone tissue engineering applications. Controlled release of naturally derived biomolecules from a three-dimensional (3D) printed implant may improve implant-host tissue integration, new bone formation, bone healing, and blood vessel growth. The present review introduces us to the current progress and limitations of 3D printed bone implants with drug delivery capabilities, followed by an in-depth discussion on cutting-edge technologies for incorporating natural medicinal compounds embedded within the 3D printed scaffolds or on implant surfaces, highlighting their applications in several pre- and post-implantation bonerelated disorders.
引用
收藏
页码:848 / 875
页数:28
相关论文
共 205 条
[41]   The biology and future prospects of antivirulence therapies [J].
Cegelski, Lynette ;
Marshall, Garland R. ;
Eldridge, Gary R. ;
Hultgren, Scott J. .
NATURE REVIEWS MICROBIOLOGY, 2008, 6 (01) :17-27
[42]   Antibacterial activation of hydroxyapatite (HA) with controlled porosity by different antibiotics [J].
Chai, F. ;
Hornez, J. -C. ;
Blanchemain, N. ;
Neut, C. ;
Descamps, M. ;
Hildebrand, H. F. .
BIOMOLECULAR ENGINEERING, 2007, 24 (05) :510-514
[43]   Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts [J].
Chang, Run ;
Sun, Linlin ;
Webster, Thomas J. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 :461-465
[44]   Toxicity of Herbs, Vitamins, and Supplements [J].
Charen, Elliot ;
Harbord, Nikolas .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2020, 27 (01) :67-71
[45]   Exosome nanovesicles: A potential carrier for therapeutic delivery [J].
Chavda, Vivek P. ;
Pandya, Anjali ;
Kumar, Lalit ;
Raval, Nidhi ;
Vora, Lalitkumar K. ;
Pulakkat, Sreeranjini ;
Patravale, Vandana ;
Duo, Yanhong ;
Tang, Ben Zhong .
NANO TODAY, 2023, 49
[46]   Zero-order controlled release of BMP2-derived peptide P24 from the chitosan scaffold by chemical grafting modification technique for promotion of osteogenesis in vitro and enhancement of bone repair in vivo [J].
Chen, Yan ;
Liu, Xujie ;
Liu, Rui ;
Gong, Yong ;
Wang, Mingbo ;
Huang, Qianli ;
Feng, Qingling ;
Yu, Bo .
THERANOSTICS, 2017, 7 (05) :1072-1087
[47]   Zirconia in biomedical applications [J].
Chen, Yen-Wei ;
Moussi, Joelle ;
Drury, Jeanie L. ;
Wataha, John C. .
EXPERT REVIEW OF MEDICAL DEVICES, 2016, 13 (10) :945-963
[48]   Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment [J].
Colilla, Montserrat ;
Vallet-Regi, Maria .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) :1-32
[49]   Porous hydroxyapatite tablets as carriers for low-dosed drugs [J].
Cosijns, A. ;
Vervaet, C. ;
Luyten, J. ;
Mullens, S. ;
Siepmann, F. ;
Van Hoorebeke, L. ;
Masschaele, B. ;
Cnudde, V. ;
Remon, J. P. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 67 (02) :498-506
[50]   Exosomes derived from mineralizing osteoblasts promote ST2 cell osteogenic differentiation by alteration of microRNA expression [J].
Cui, Yazhou ;
Luan, Jing ;
Li, Haiying ;
Zhou, Xiaoyan ;
Han, Jinxiang .
FEBS LETTERS, 2016, 590 (01) :185-192